The Cefadroxil Market is poised for significant expansion, with a forecasted growth trajectory suggesting it will reach approximately USD 0.4988 billion by 2035. This growth signals a compound annual growth rate (CAGR) of 3.50%, reflecting the increasing prevalence of bacterial infections and a heightened awareness of antibiotic stewardship among healthcare providers. The market's evolution...